Editorial
Nat. Biotechnol. 22, 133 (2004)
On line 16 of the editorial, both Samyang Genex (Daejeon, Korea) and Maxygen (Redwood City, CA, USA) were wrongly indicated to be exploring the expression of biopharmaceuticals in corn. This erroneous information was obtained from a report A Strategic Evaluation of Transgenic Plant and Animal Biomanufacturing Systems (Revelogic, Ft. Collins, CO, USA, 2003). In fact, Samyang Genex has a corn processing plant and uses plant cell culture to produce paclitaxel, whereas Maxygen has no program focus on expressing biopharmaceuticals in corn.
Additional information
The online version of the original article can be found at 10.1038/nbt0204-133
Rights and permissions
About this article
Cite this article
Erratum: Drugs in crops—the unpalatable truth. Nat Biotechnol 22, 459 (2004). https://doi.org/10.1038/nbt0404-459a
Issue Date:
DOI: https://doi.org/10.1038/nbt0404-459a
